肺部侵袭性粘膜腺癌癌
Wei-Chin Chang1,2, Yu Zhi Zhang3,4, Andrew G Nicholson3,4
1Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan.
Histopathology
|October 23, 2023
概括
侵入性粘膜腺癌 (IMA) 是一种罕见的肺癌亚型,具有独特的特征和分子驱动因素,如KRAS突变,NRG1和ERBB2融合. 了解这些区别对于开发有针对性的疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 基因组学就是基因组学.
背景情况:
- 侵入性粘膜腺癌 (IMA) 是一种罕见的肺腺癌亚型,其特征是带有细胞内粘膜的杯状/柱状细胞.
- 虽然KRAS突变很常见,但越来越多地发现了像NRG1和ERBB2融合这样的独特基因组变异.
- IMAs经常表现出类似肺炎的模式与多焦点参与,表明肺内转移.
研究的目的:
- 审查最近在IMA的组织病理学,临床和分子特征方面的进展.
- 要突出IMA的独特特征,需要与非性腺癌相比,不同的治疗策略.
- 识别和讨论IMA未来研究的未解决问题.
主要方法:
- 关于侵袭性粘膜腺癌的最近研究的文献综述.
- 从已发表的研究中分析了基因病理学,临床和分子数据.
- 对比的基因组分析解释.
主要成果:
- IMA是由特定的细胞形态和粘素含量来定义的.
- 关键的分子驱动因素包括KRAS突变,NRG1和ERBB2融合.
- 独特的临床表现和基因组资料表明肺内传播.
结论:
- IMA 具有独特的 组织病理学,临床和分子特征.
- 这些独特的特征需要量身定制的治疗方法.
- 需要进一步的研究,以解决IMA管理中的当前知识差距.
相关概念视频
Pulmonary Tuberculosis II
243
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
Other Pulmonary Disorders
854
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
854


